Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Shouki Bazarbashi"'
Autor:
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Sherif Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEMetastatic colorectal cancer (mCRC) is a significant global health burden. This retrospective study compared the effectiveness of trifluridine/tipiracil (FTD/TPI), regorafenib, and chemotherapy rechallenge for third-line mCRC treatment.MATERIA
Externí odkaz:
https://doaj.org/article/350a57fe7f124621a954fd89e8b71505
Autor:
Shouki Bazarbashi, Mohamed Aseafan, Tasnim Elgazzar, Maha Alkhayat, Abdulrahman Alghabban, Marwa I. Abdelgawad, Bader Alshamsan, Aisha Alshibany, Tusneem Elhassan, Ali Aljubran, Ahmed Alzahrani, Hindi Alhindi, Hussein Raef
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Gastroenteropancreatic Neuroendocrine tumors (GEP-NET) are rare neoplasms with limited reported data from the Middle East. Our study aims to report the clinicopathological feature, treatment patterns, and survival outcomes of pati
Externí odkaz:
https://doaj.org/article/7dc2f539f59c4ff5b430a320d1a04bcb
Autor:
Shouki Bazarbashi, Mahmoud A. Elshenawy, Ahmed Badran, Ali Aljubran, Ahmed Alzahrani, Hadeel Almanea, Abdullah Alsuhaibani, Ahmed Alashwah, Mohamed Neimatallah, Alaa Abduljabbar, Luai Ashari, Samar Alhomoud, Hazem Ghebeh, Tusneem Elhassan, Nasser Alsanea, Mohammed Mohiuddin
Publikováno v:
Cancer Medicine, Vol 11, Iss 10, Pp 2056-2066 (2022)
Abstract Introduction Gemcitabine is a well‐known radiosensitizer. Herein, we tested the efficacy and toxicity of preoperative concurrent infusional gemcitabine and radiotherapy in locally advanced rectal cancer. Patients and Methods This was a pha
Externí odkaz:
https://doaj.org/article/0e12e351a0ec409f90b34578dcb818b7
Autor:
Shouki Bazarbashi, Abdullah Alsharm, Alaa Meshref, Hind Mrabti, Jawaher Ansari, Marwan Ghosn, Mohamed Abdulla, Yuksel Urun
Publikováno v:
Urology Annals, Vol 14, Iss 4, Pp 303-313 (2022)
Despite the reliance on Western guidelines for managing prostate cancer (PC), there are wide variations and gaps in treatment among developing countries such as the Middle East African (MEA) region. A multidisciplinary team of experts from the MEA re
Externí odkaz:
https://doaj.org/article/400a15a07b5e43b8bdfc3e7b29b13ce6
Autor:
Mohamed Aseafan, Edward Devol, Mahmoud AlAhwal, Riad Souissi, Reham Sindi, Haya AlEid, Shouki Bazarbashi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The Saudi Cancer Registry reported in 2007 the 5-year observed survival for the most common cancer sites for the years 1994–2004. In this report we looked at the cancer survival in the period 2005–2009 and evaluated the trend over the 15
Externí odkaz:
https://doaj.org/article/ba5479529cab438fa275d1d26698bacd
Autor:
Mohammed Alsheef, Shouki Bazarbashi, Ashraf Warsi, Feras Alfraih, Abdualkreem Almoomen, Ahmed Osman, Tarek Owaidah
Publikováno v:
TH Open, Vol 07, Iss 01, Pp e14-e29 (2023)
Background Cancer is a well-known risk factor of preventable thromboembolic disease. This study aims to provide guidance on the prevention and management of cancer-associated thrombosis (CT) that tailors prophylactic and therapeutic options for medic
Externí odkaz:
https://doaj.org/article/840efcbf2c9a4357bebbc2db3cf6c3b9
Autor:
Nora Alkhudair, Majed Alshamrani, Hadeel Samarkandi, Hajer Almodaheem, Hana Alabdulkarim, Mai Alsaqaaby, Fouad Alnajjar, Hashem Alhashem, Mohammed Bakkar, Shouki Bazarbashi, Mohammed Alnahedh, Feras Alfraih, Mohammad Alawagi, Ahmed Al-jedai
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 2, Pp 115-120 (2021)
Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the i
Externí odkaz:
https://doaj.org/article/abcd3f7b889a4b59afe9b1084389dcfb
Publikováno v:
MDM Policy & Practice, Vol 7 (2022)
Objective The recent establishment of the health technology assessment (HTA) entity in the Kingdom of Saudi Arabia (KSA) has resulted in increased interest in economic evaluation. The aim of this study is to evaluate the technical approaches used in
Externí odkaz:
https://doaj.org/article/a9f936c39461447190d055cd0bb42f02
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1609-1616 (2020)
PURPOSEHealth utilities (HUs) are quantitative measures of quality of life that are used to derive outcomes such as quality-adjusted life years in cost-effectiveness analyses. In the Kingdom of Saudi Arabia, there are no HUs for cancer. This study ai
Externí odkaz:
https://doaj.org/article/f75abeed6c9c4809a654cef3a0a0ac34
Autor:
Ahmed Badran, Mahmoud A. Elshenawy, Amgad Shahin, Ali Aljubran, Ahmed Alzahrani, Abdelmoneim Eldali, Shouki Bazarbashi
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 19-26 (2020)
PURPOSEAntiangiogenic tyrosine kinase inhibitors have been the mainstay first-line therapy for metastatic renal cell carcinoma (mRCC). We reviewed the efficacy of first-line therapy with sunitinib in patients with mRCC in an Arab population.METHODSMe
Externí odkaz:
https://doaj.org/article/4fb9cddfe9bd4f2894cb1c01c1950702